Skip to main content
Erschienen in: Wiener klinische Wochenschrift 15-16/2015

01.08.2015 | original article

Thyroid screening in HIV-infected patients with antiretroviral therapy

verfasst von: Margit Hatzl, MD, Angela Öllinger, MD, Maria Geit, MD, Klaus Wiesinger, Kristina Angerbauer, Prof. Josef Auböck, MD, Prof. Mag. Michael Gabriel, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 15-16/2015

Einloggen, um Zugang zu erhalten

Summary

Background

The literature reports an increased incidence of thyroid disorders in human immunodeficiency virus (HIV)-positive persons. We therefore retrospectively analyzed the strategy of collecting thyroid parameters on a routine basis.

Methods

Overall 410 patients (147 women, 263 men; age, 10–74 years; median age, 45 years) were included. For screening purposes, three parameters were determined; basal thyroid-stimulating hormone (TSH), free thyroxine (fT4), and free triiodothyronine (fT3). Descriptive and statistical analyses were performed in the patient groups with increased bTSH (> 4.0 µU/ml) and with decreased fT4 (< 8.9 pg/ml) to evaluate possible correlation with age, gender, duration of antiretroviral therapy (ART), substance classes of ART (nucleosidal reverse transcriptase inhibitors (NRTIs), nonnucleosidal reverse transcriptase inhibitors, and protease inhibitors (PIs)), Centers for Disease Control and Prevention (CDC) disease stage, lowest number of CD4 cells during course of disease, and coexistent hepatitis C.

Results

Elevated bTSH was found in 27 patients (median, 5.26 µU/ml), who also showed a correlation with ART duration and NRTI use. Decreased fT4 was seen in 53 persons, and a correlation with PI intake was observed. Of these patients, 31 exhibited normalization in follow-up. Decreased fT3 was observed in eight cases related to nonthyroid illness, and fT3 was elevated in ten patients. No overt hyperthyroidism was noticed; three cases of subclinical hyperthyroidism were transient.

Conclusions

In the examined group of patients, the prevalence of abnormal thyroidal parameters was 23 %. Decreased fT4, which does not require therapy, was observed most frequently (12 %) and correlated with PI use. On the other hand, elevated bTSH (6 %) correlated with ART duration and NRTI use. In mild subclinical hypothyroidism as observed in this patient population, thyroxine medication is not indicated in principle. Annual TSH screening is probably sufficient in HIV-infected patients with no clinical symptoms suggestive for thyroid disease.
Literatur
1.
Zurück zum Zitat Norbiato G. Endocrine, metabolic, and immunologic components of HIV infection. Ann N Y Acad Sci. 2012;1262:51–5.CrossRefPubMed Norbiato G. Endocrine, metabolic, and immunologic components of HIV infection. Ann N Y Acad Sci. 2012;1262:51–5.CrossRefPubMed
2.
Zurück zum Zitat Nelson M, Powles T, Zeitlin A, Sen P, Scourfield A, Bower M, et al. Thyroid dysfunction and relationship to antiretroviral therapy in HIV-positive individuals in the HAART era. J Acquir Immun Defic Syndr. 2009;50(1):113–4.CrossRef Nelson M, Powles T, Zeitlin A, Sen P, Scourfield A, Bower M, et al. Thyroid dysfunction and relationship to antiretroviral therapy in HIV-positive individuals in the HAART era. J Acquir Immun Defic Syndr. 2009;50(1):113–4.CrossRef
3.
Zurück zum Zitat Collazos J, Ibarra S, Mayo J. Thyroid hormones in HIV-infected patients in the highly active antiretroviral therapy era: evidence of an interrelation between the thyroid axis and the immune system. AIDS. 2003;17(5):763–5.CrossRefPubMed Collazos J, Ibarra S, Mayo J. Thyroid hormones in HIV-infected patients in the highly active antiretroviral therapy era: evidence of an interrelation between the thyroid axis and the immune system. AIDS. 2003;17(5):763–5.CrossRefPubMed
4.
Zurück zum Zitat Madeddu G, Spanu A, Chessa F, Calia GM, Lovigu C, Solinas P, et al. Thyroid function in human immune deficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study. Clin Endocrinol. 2006;64(4):375–83. Madeddu G, Spanu A, Chessa F, Calia GM, Lovigu C, Solinas P, et al. Thyroid function in human immune deficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study. Clin Endocrinol. 2006;64(4):375–83.
5.
Zurück zum Zitat Beltran S, Lescure FX, Desailloud R, Douadi Y, Smail A, El Esper I, et al. Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: a need for screening. Clin Infect Dis. 2003;37(4):579–83.CrossRefPubMed Beltran S, Lescure FX, Desailloud R, Douadi Y, Smail A, El Esper I, et al. Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: a need for screening. Clin Infect Dis. 2003;37(4):579–83.CrossRefPubMed
6.
Zurück zum Zitat Hommes MJ, Romijn JA, Godfried MH, Schattenkerk JK, Buurman WA, Endert E, et al. Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism. 1990;39:1186–90.CrossRefPubMed Hommes MJ, Romijn JA, Godfried MH, Schattenkerk JK, Buurman WA, Endert E, et al. Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism. 1990;39:1186–90.CrossRefPubMed
7.
Zurück zum Zitat Lambert M. Thyroid dysfunction in HIV infection. Baillieres Clin Endocrinol Metab. 1994; 8(4):825–35.CrossRefPubMed Lambert M. Thyroid dysfunction in HIV infection. Baillieres Clin Endocrinol Metab. 1994; 8(4):825–35.CrossRefPubMed
8.
Zurück zum Zitat Sellmeyer DE, Grunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev. 1996;17(5):518–32.PubMed Sellmeyer DE, Grunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev. 1996;17(5):518–32.PubMed
9.
Zurück zum Zitat Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome”. Endocr Rev. 1982;3(2):164–217.CrossRefPubMed Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome”. Endocr Rev. 1982;3(2):164–217.CrossRefPubMed
10.
Zurück zum Zitat LoPresti JS, Fried JC, Spencer CA, Nicoloff JT. Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989;110(12):970–5.CrossRefPubMed LoPresti JS, Fried JC, Spencer CA, Nicoloff JT. Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989;110(12):970–5.CrossRefPubMed
11.
Zurück zum Zitat Grunfeld C, Pang M, Doerrler W, Jensen P, Shimizua L, Feingold KR, et al. Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism. 1993;42(10):1270.CrossRefPubMed Grunfeld C, Pang M, Doerrler W, Jensen P, Shimizua L, Feingold KR, et al. Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism. 1993;42(10):1270.CrossRefPubMed
12.
Zurück zum Zitat Ohnhaus EE, Bürgi H, Burger A, Studer H. The effect of antipyrine, phenobarbitol and rifampicin on thyroid hormone metabolism in man. Eur J Clin Invest. 1981;11(5):381–7.CrossRefPubMed Ohnhaus EE, Bürgi H, Burger A, Studer H. The effect of antipyrine, phenobarbitol and rifampicin on thyroid hormone metabolism in man. Eur J Clin Invest. 1981;11(5):381–7.CrossRefPubMed
13.
Zurück zum Zitat Carella C, Mazziotti G, Amato G, Braverman LE, Roti E. Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. J Clin Endocr Metab. 2004;89(8):3656–61.CrossRefPubMed Carella C, Mazziotti G, Amato G, Braverman LE, Roti E. Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. J Clin Endocr Metab. 2004;89(8):3656–61.CrossRefPubMed
14.
Zurück zum Zitat Jubault V, Penfornis A, Schillo F, Hoen B, Izembart M, Timsit J, et al. Sequential occurrence of thyroid autoantibodies and Graves’ disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients. J Clin Endocrl Metab. 2000;85(11):4254–7. Jubault V, Penfornis A, Schillo F, Hoen B, Izembart M, Timsit J, et al. Sequential occurrence of thyroid autoantibodies and Graves’ disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients. J Clin Endocrl Metab. 2000;85(11):4254–7.
15.
Zurück zum Zitat Gilquin J, Viard JP, Jubault V, Sert C, Kazatchkine MD. Delayed occurrence of Graves’ disease after immune restoration with HAART. Highly active antiretroviral therapy. Lancet. 1998;352(9144):1907–8.CrossRefPubMed Gilquin J, Viard JP, Jubault V, Sert C, Kazatchkine MD. Delayed occurrence of Graves’ disease after immune restoration with HAART. Highly active antiretroviral therapy. Lancet. 1998;352(9144):1907–8.CrossRefPubMed
16.
Zurück zum Zitat Crum NF, Ganesan A, Johns ST, Wallace MR. Graves disease: an increasingly recognized immune reconstitution syndrome. AIDS. 2006;20(3):466–9.CrossRefPubMed Crum NF, Ganesan A, Johns ST, Wallace MR. Graves disease: an increasingly recognized immune reconstitution syndrome. AIDS. 2006;20(3):466–9.CrossRefPubMed
17.
Zurück zum Zitat Rasul S, Delapenha R, Farhat F, Gajjala J, Zahra SM. Graves’ disease as a manifestation of immune reconstitution in HIV-infected individuals after initiation of highly active antiretroviral therapy. AIDS Res Treat. 2011;2011:743597. doi:10.1155/2011/743597.PubMedCentralPubMed Rasul S, Delapenha R, Farhat F, Gajjala J, Zahra SM. Graves’ disease as a manifestation of immune reconstitution in HIV-infected individuals after initiation of highly active antiretroviral therapy. AIDS Res Treat. 2011;2011:743597. doi:10.1155/2011/743597.PubMedCentralPubMed
18.
Zurück zum Zitat Madge S, Smith CJ, Lampe FC, Thomas M, Johnson MA, Youle M, et al. No association between HIV disease and its treatment and thyroid function. HIV Med. 2007;8(1):22–7.CrossRefPubMed Madge S, Smith CJ, Lampe FC, Thomas M, Johnson MA, Youle M, et al. No association between HIV disease and its treatment and thyroid function. HIV Med. 2007;8(1):22–7.CrossRefPubMed
19.
Zurück zum Zitat Hoffmann CJ, Brown TT. Thyroid function abnormalities in HIV-infected patients. Clin Infect Dis. 2007;45(4):488–94.CrossRefPubMed Hoffmann CJ, Brown TT. Thyroid function abnormalities in HIV-infected patients. Clin Infect Dis. 2007;45(4):488–94.CrossRefPubMed
20.
Zurück zum Zitat Caregaro L, Alberino F, Amodio P, Merkel C, Angeli P, Plebani M, et al. Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis. J Hepatol. 1998;28(1):115–21.CrossRefPubMed Caregaro L, Alberino F, Amodio P, Merkel C, Angeli P, Plebani M, et al. Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis. J Hepatol. 1998;28(1):115–21.CrossRefPubMed
21.
Zurück zum Zitat Slag MF, Morley JE, Elson MK, Crowson TW, Nuttal FQ, Shafer RB. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA. 1981;245(1):43–5.CrossRefPubMed Slag MF, Morley JE, Elson MK, Crowson TW, Nuttal FQ, Shafer RB. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA. 1981;245(1):43–5.CrossRefPubMed
22.
Zurück zum Zitat Ezeala C, Chukwurah E. Hypothyroxinemia in acquired immune deficiency syndrome (AIDS). Cent Afr J Med. 1994;40(8):226–9.PubMed Ezeala C, Chukwurah E. Hypothyroxinemia in acquired immune deficiency syndrome (AIDS). Cent Afr J Med. 1994;40(8):226–9.PubMed
23.
Zurück zum Zitat Beltran S, Lescure FX, El Esper I, Schmit JL, Desailloud R. Subclinical hypothyroidism in HIV-infected patients is not an autoimmune disease. Horm Res. 2006;66(1):21–6.CrossRefPubMed Beltran S, Lescure FX, El Esper I, Schmit JL, Desailloud R. Subclinical hypothyroidism in HIV-infected patients is not an autoimmune disease. Horm Res. 2006;66(1):21–6.CrossRefPubMed
24.
Zurück zum Zitat Villar HCCE, Saconato H, Valent O, Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev. 2007;(3):CD003419. Villar HCCE, Saconato H, Valent O, Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev. 2007;(3):CD003419.
25.
Zurück zum Zitat Strieder TG, Prummel MF, Tijssen JG, Endert E, Wiersinga WM. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol 2003;59(3):396–401.CrossRef Strieder TG, Prummel MF, Tijssen JG, Endert E, Wiersinga WM. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol 2003;59(3):396–401.CrossRef
26.
Zurück zum Zitat Bouillet B, Petit JM, Piroth L, Duong M, Bourg JB. A case of subacute thyroiditis associated with primary HIV infection. Am J Med. 2009;122(4):e5–6.CrossRefPubMed Bouillet B, Petit JM, Piroth L, Duong M, Bourg JB. A case of subacute thyroiditis associated with primary HIV infection. Am J Med. 2009;122(4):e5–6.CrossRefPubMed
27.
Zurück zum Zitat Vigano A, Riboni S, Bianchi R, Cafarelli L, Vago T, Manzoni P, et al. Thyroid dysfunction in antiretroviral treated children. Pediatr Infect Dis J. 2004;23(3):235–9.CrossRefPubMed Vigano A, Riboni S, Bianchi R, Cafarelli L, Vago T, Manzoni P, et al. Thyroid dysfunction in antiretroviral treated children. Pediatr Infect Dis J. 2004;23(3):235–9.CrossRefPubMed
Metadaten
Titel
Thyroid screening in HIV-infected patients with antiretroviral therapy
verfasst von
Margit Hatzl, MD
Angela Öllinger, MD
Maria Geit, MD
Klaus Wiesinger
Kristina Angerbauer
Prof. Josef Auböck, MD
Prof. Mag. Michael Gabriel, MD
Publikationsdatum
01.08.2015
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 15-16/2015
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-015-0733-7

Weitere Artikel der Ausgabe 15-16/2015

Wiener klinische Wochenschrift 15-16/2015 Zur Ausgabe

mitteilungen der gesellschaft

ÖGIM FLIP